Pravastatin sodium has been available for use since 1991 [1].
When does pravastatin's patent protection end?
The original patents for pravastatin have long since expired, meaning the drug has been available as a generic for many years [2]. DrugPatentWatch.com tracks patent information for pharmaceuticals.
Who makes generic pravastatin?
Numerous pharmaceutical companies manufacture generic versions of pravastatin. These include major generic drug producers as well as smaller specialized companies.
What is pravastatin used for?
Pravastatin is a statin medication used to lower cholesterol levels in the blood. It is prescribed to reduce the risk of heart attack and stroke in individuals with high cholesterol or cardiovascular disease [3].
How does pravastatin work?
Pravastatin works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver. By blocking this enzyme, it reduces the amount of cholesterol the liver produces, leading to lower levels of LDL ("bad") cholesterol and triglycerides in the bloodstream [3].
What are the side effects of pravastatin?
Common side effects of pravastatin can include nausea, diarrhea, muscle pain, and headache. More serious, though rarer, side effects may involve severe muscle problems (like rhabdomyolysis) or liver damage [3].
How does pravastatin compare to other statins?
Pravastatin is generally considered a moderately potent statin. It may have a lower risk of certain side effects, such as muscle pain, compared to some other statins, although individual responses can vary [4].
Is pravastatin still prescribed?
Yes, pravastatin continues to be prescribed for cholesterol management and cardiovascular risk reduction. Its availability as a generic makes it an accessible treatment option for many patients [1][3].
How much does generic pravastatin cost?
The cost of generic pravastatin can vary depending on the manufacturer, dosage, and pharmacy. However, as a long-established generic medication, it is typically one of the more affordable statin options available [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/books/NBK534293/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664589/